Effectiveness and Safety of Simnotrelvir/Ritonavir and Nirmatrelvir/Ritonavir in the Treatment of Moderate to Severe COVID‐19
ABSTRACT Background and Aim Simnotrelvir/ritonavir and nirmatrelvir/ritonavir are major treatments for COVID‐19, but their comparative efficacy and safety, especially in patients with moderate to severe COVID‐19, remain unclear. Methods This was a retrospective cohort study using electronic medical...
Na minha lista:
| Principais autores: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Wiley
2025-04-01
|
| Serier: | Immunity, Inflammation and Disease |
| Fag: | |
| Online adgang: | https://doi.org/10.1002/iid3.70174 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
